GB2107341A - Low shrinkage polymer/monomer mixtures for biomedical use - Google Patents
Low shrinkage polymer/monomer mixtures for biomedical use Download PDFInfo
- Publication number
- GB2107341A GB2107341A GB08228973A GB8228973A GB2107341A GB 2107341 A GB2107341 A GB 2107341A GB 08228973 A GB08228973 A GB 08228973A GB 8228973 A GB8228973 A GB 8228973A GB 2107341 A GB2107341 A GB 2107341A
- Authority
- GB
- United Kingdom
- Prior art keywords
- methacrylate
- process according
- polymeric material
- solid component
- liquid component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/884—Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
- A61K6/887—Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
- C08F220/28—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety
- C08F220/281—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety and containing only one oxygen, e.g. furfuryl (meth)acrylate or 2-methoxyethyl (meth)acrylate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F265/00—Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated monocarboxylic acids or derivatives thereof as defined in group C08F20/00
- C08F265/04—Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated monocarboxylic acids or derivatives thereof as defined in group C08F20/00 on to polymers of esters
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04R—LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS
- H04R25/00—Deaf-aid sets, i.e. electro-acoustic or electro-mechanical hearing aids; Electric tinnitus maskers providing an auditory perception
- H04R25/65—Housing parts, e.g. shells, tips or moulds, or their manufacture
- H04R25/658—Manufacture of housing parts
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04R—LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS
- H04R25/00—Deaf-aid sets, i.e. electro-acoustic or electro-mechanical hearing aids; Electric tinnitus maskers providing an auditory perception
- H04R25/65—Housing parts, e.g. shells, tips or moulds, or their manufacture
- H04R25/652—Ear tips; Ear moulds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Manufacturing & Machinery (AREA)
- General Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Signal Processing (AREA)
- Acoustics & Sound (AREA)
- Physics & Mathematics (AREA)
- Otolaryngology (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Dental Preparations (AREA)
- Materials For Medical Uses (AREA)
Abstract
A process for the preparation of a polymeric material that has a linear curing shrinkage of 1% or less involves mixing a liquid component containing, as its sole polymerisable constituent, one or more monomeric esters of general formula (I) <IMAGE> wherein R is a hydrogen atom or a methyl radical and n is 1, 2, 3 or 4, with a solid component containing an acrylate polymer, a methacrylate polymer or a copolymer of these polymers, and initiating the polymerisation of the one or more monomeric esters in the liquid component. Preferred materials are tetrahydrofurfuryl methacrylate in the liquid component and polyethyl methacrylate in the solid component. The polymerisation is preferably initiated by benzoyl peroxide in the presence of a chemical activator, specially N,N-dimethyl-p-toluidine. These components may be supplied in the form of a kit for use in the process. The polymeric materials produced are particularly suitable for use in the formation of biomedical appliances, such as hearing aids, tooth filling, dental bridges and crowns, false teeth, artificial eyes and contact lenses, or for use in other biomedical applications, for example as a bone cement.
Description
SPECIFICATION
Low shrinkage polymers
The present invention relates to polymers that have a low linear shrinkage during the room temperature polymeric curing process and, in particular, to low shrinkage polymers that are useful for biomedical use.
The term "biomedical" as used hereinafter encompasses the medical (including aural), opthalmic, surgical, dental and related fields, whilst the term "biomedical appliance" refers to an appliance, such as a hearing aid, artificial eyes, contact lenses, a tooth filling or crown, dentures or a bone cement, that may be used in one or more of these fields.
When a polymeric material is employed in a situation requiring dimensional accuracy, for example in dental and hearing aid applications, one of the most important properties to be considered is its dimensional stability.
The particular synthetic resin most used at present in the dental and hearing aid fields is poly(methyl methacrylate). In a typical molding procedure, this polymer, in powdered form, is first mixed with its liquid monomer, methyl methacrylate. The monomer partially dissolves the polymer to form a plastic dough which is then packed into a suitable mold. Finally the monomer is polymerised, by heat or chemical activation, to give a hard, transparent material.
When methyl methacrylate monomer is polymerised the density changes, from 0.94 to 1.19 gms per cc, resulting in a volumetric shrinkage of 21%. If the conventional powder-liquid process, out-lined above, is used in the molding procedure, approximately one-third of the volume of the dough is monomer. Consequently the average volume shrinkage of the dough during the polymerisation step will be about 7%. This is equivalent to a linear curing shrinkage of between about 2 and 23%.
Clearly such a high degree of shrinkage is undesirable since it may lead to errors being made in the molding process, producing, for example, ill fitting dentures and/or hearing appliances. There is therefore a need for a polymeric material that has a low linear curing shrinkage and, preferably, that may be used as a biomedical material, particularly in the dental and aural fields.
According to the present invention there is provided a process for the preparation of a polymeric material suitable for biomedical use and having a linear curing shrinkage of 1% or less which comprises mixing a liquid component which contains, as its sole polymerisable constituent, one or more monomeric esters of general formula I
wherein R is a hydrogen atom or a methyl radical and n is 1, 2, 3 or 4, with a solid component which comprises one or more polymers selected from the group consisting of an acrylate polymer, a methacrylate polymer and a copolymer of these polymers, and initiating the polymerisation of the one or more monomeric esters in the liquid component.
Preferably the linear shrinkage of the polymeric material is between 0.2 and 1%. Moreover, in preferred embodiments of the present process the monomeric esters are methacrylate (R=CH3) esters wherein n is 1, 2 or 3, with tetrahydrofurfuryl methacrylate (R=CH3, n=3) being particularly preferred.
Although a mixture of two or more monomeric esters may be added to the polyacrylate, polymethacrylate or copolymeric esters in the solid component to form a polymeric material according to the present invention, the addition of only one monomeric ester, particularlytetrahydrofurfuryl- methacrylate, is preferred.
The acrylate or methacrylate ester polymers that are eontained in the solid component may be in either homopolymeric or copolymeric form. Preferably the polymeric esters have a softening point (Tg) above about 500C. In particularly preferred embodiments of the process of the present invention the polymeric esters are selected from the group consisting of polymethyl, polyethyl, polypropyl or polybutyl methacrylate or copolymers of these polymers. Polyethyl methacrylate and copolymers of this polymer with polymethyl, polypropyl and polybutyl methacrylate are especially preferred.
Although a mixture of two or more polymeric esters may be admixed with the monomeric acrylate of methacrylate esters to form a polymeric material according to the present invention, the use of only one polymeric ester, particularly polymethyl methacrylate is preferred.
In another aspect of the present invention the polymeric esters in the solid component, prior to admixing with the monomeric esters in the liquid component, may be admixed with up to 10% (by wt) of an inorganic filler, such as finely-divided alumina silicates, silica, quartz, glass, and the like. However, if an inorganic filler is used it is important that the physical and chemical properties of the polymeric material produced do not differ significantly from the properties of the equivalent inorganic filler free polymeric material.
On mixing the polymers of the solid component and monomers of the liquid component, the polymerisation of the monomers in the liquid component may be initiated by any of the polymerisation initiators that are well known in the polymer art. Typically, however, free radical catalysts, such as the organic peroxides, benzoyl peroxide and lauroyl peroxide, are used. Often a residual amount of the peroxides may be present in the polymer of the solid component. If this is the case it may not be necessary to add any more of the catalyst. On the other hand if there is not sufficient residual peroxide present, it should be added, preferably to the solid component, until a suitable concentration is present.
The initiators, particularly benzoyl peroxide, may be activated by using heat. Preferably, however, activation is effected with the aid of a chemical activator, so that the polymerisation may be completed at room temperature (so-called "cold curing"). Preferred activators include organic tertiary amines, such as N,N-dialkyl-p-toluidines, N,N-dialkyi anilines and N-p-tolyl-dialkanolamines. In particular preferred embodiments of the process of the present invention the activator is selected from the group consisting of N,N-dimethyl-p-toluidine, N,N-diethyl-p-toluidine, N,N-dimethylaniline and N-p-toluenediethanolamine. Preferably the chemical activator is present in the liquid component prior to mixing.
Other conventional initiators and activators, while not at present preferred, may be used in place of or together with the above substances, provided they lead to an efficient polymerisation step.
Further additives, such as pigments, to produce a coloured material, and stabilising agents (for example sulphinic acid derivatives, especially p-toluenesulphinic acid), to prevent oxidation of the tertiary amines and thereby to stabilise the colour of the resultant polymeric material, may be present in the initial reaction mixture.
The ratio of polymer in the solid component to monomer in the liquid component that is used to form the preferred polymeric material of the present invention is determined by a number of factors. In general, the more polymer that is used, the less will be the reaction time between the polymer and the monomer. By contrast, the resin will tend to shrink less during processing if less monomer is used. On the other hand, sufficient monomer must be employed to wet the polymer thoroughly, the choice of polymer/monomer ratio is therefore one of compromise. In a preferred embodiment of the present invention the polymer/monomer ratio is between 3 to 1 and 1.5 to 1 by weight.
The formation of the polymeric material in the process of the present invention by mixing ester polymers with ester monomers in the presence of initiators and activators is characterised by four distinct stages.
1. On mixing polymer with monomer a fluid, incoherent mass is formed.
2. The mixture then becomes tacky and, if pulled apart, exhibits a fibrous nature.
3. The mixture loses its tacky quality and becomes smooth and dough like. This is referred to as the dough or gel stage.
4. The mass becomes cohesive and rubber-like.
The time required to reach stage 3 depends on the solubility of the polymer in the monomer. This time will depend on a number of factors, but especially on the temperature of the reaction and the size of the polymer particles. Generally, the higher the temperature and the smaller the particle size, the faster stage 3 will be reached. In a preferred embodiment of the present invention the reaction to reach the dough stage is conducted at a temperature of between about 1 5 and 400C whilst the mesh size of the ester polymer is between about 200 and 300.
It is during stage 3 that the preferred polymeric material of the present invention is molded into a required shape, particularly that of a biomedical appliance. For the manufacture of hearing aids, dentures, tooth fillings and crowns, it is preferred that the dough stage 3 should last at least 5 minutes.
In order to achieve this with the preferred materials of the present invention, using a polymer with a mesh size of 200 to 300, the reaction should be conducted at a temperature of between about 1 5 and 400C, preferably between about 20 and 250C.
The present process will be used predominantly in the biomedical area, for example in dental surgeries and laboratories or in medical laboratories. In order to facilitate the use of the process in such areas there is also provided, in a further aspect of the present invention, a kit for use in the preparation of a polymeric material comprising a liquid component which contains, as its sole polymerisable constituent, one or more monomeric esters of general formula I
wherein R is a hydrogen atom or a methyl radical and n is 1, 2, 3 or 4, and a solid component which comprises one or more polymers selected from the group consisting of an acrylate polymer, a methacrylate polymer and a copolymer of these polymers.
In preferred embodiments of the present kit the monomeric esters are methacrylate (R=CH3) esters wherein n is 1, 2 or 3, with tetrahydrofurfuryl methacrylate (R=CH3, n=3) being particularly preferred.
Although a mixture of two or more monomeric esters may be used in the liquid component of the present kit, it is preferred that the liquid component contains only one monomeric ester, preferably tetrahydrofurfuryl methacrylate.
The acrylate or methacrylate ester polymers that are contained in the solid component of the present kit may be in either homopolymeric or copolymeric form. Preferably the polymeric esters have a softening point (Tg) above about 50 C. In particularly preferred embodiments of the present kit the polymeric esters are selected from the group consisting of polymethyl, polyethyl, polypropyl or polybutyl methacrylate or copolymers of these polymers. Polyethyl methacrylate and copolymers of this polymer with polymethyl, polypropyl and polybutyl methacrylate are especially preferred.
Although a mixture of two or more polymers may be used in the solid component of the present kit, it is preferred that the solid component contains only one polymeric ester, preferably polyethyl methacrylate.
The present kit may further comprise an inorganic filler and a polymerisation initiator. The inorganic filler, which is generally in admixture (up to 10% by wet) with the one or more polymers of the solid component, may be chosen from any of the inorganic fillers that are well known in the polymer art. Examples include finely-divided alumina silicates, silica, quartz and glass. However if an inorganic filler is used it is important that the physical and chemical properties of the polymeric material finally produced do not differ significantly from the properties of the equivalent inorganic filler free polymeric material.
The polymerisation initiator may also be any of those that are well known in the polymer art.
Typically, however, free radical catalysts, such as the organic peroxides, benzoyl peroxide and lauroyl peroxide, are used. Often a residual amount of the peroxides may be present in the polymer of the solid component. If this is the case it may not be necessary to add any more of the catalyst to the kit. On the other hand if there is not sufficient residual peroxide present, it should be added, preferably to the solid component, until a suitable concentration is present. The initiators, particularly benzoyl peroxide, may be activated by using heat. Preferably, however, activation is effected with the aid of a chemical activator, so that the polymerisation may be completed at room temperature (so-called "cold curing").
If this "cold curing" is the process of choice then the present kit may also comprise a chemical activator for the polymerisation initiator. Preferred activators include organic tertiary amines, such as
N,N-dialkyl-p-toluidines, N,N-dialkylanilines and N-p-tolyl-dialkanolamines. In particularly preferred embodiments of the kit of the present invention the activator is selected from the group consisting of
N,N-dimethyl-p-toluidine, N,N-dimethylaniline, N-p-toluene-diethanolamine and N,N-diethyl-ptoluidine. Preferably the chemical activator is present in the liquid component of the kit.
Other conventional initiators and activators, while not at present preferred, may be used in place of or together with the above substances, provided they lead to an efficient polymerisation step.
Further additives, such as pigments, to produce a coloured material, and stabilising agents (for example sulphinic acid derivatives, especiallyp-toluenesulphinic acid), to prevent oxidation of the tertiary amines and thereby stabilise the polymer's colour, may also be present in alternative embodiments of the present kit. Moreover, in order to facilitate the use of the present kit in the present princess, a set of instructions, giving process details, may also be included in a preferred form of the present kit.
The polymeric materials prepared by the process of the present invention are suitable for use in any area where a resinous or hard plastics material with low linear curing shrinkage is required.
However, the present materials are particularly suitable for use in the formation of biomedical appliances, such as hearing aids, tooth fillings, dental bridges and crowns, dentures, artificial eyes and contact lenses, or for use in other biomedical applications, for example as a bone cement.
The polymeric materials, processes of forming the polymeric materials and applications for the polymeric materials will now be described by way of example only with particular reference to the figures in which:
Figure 1 shows a polymerisation shrinkage apparatus; and
Figure 2 shows the linear polymerisation shrinkage of a number of acrylic resins against time.
Example la
Formation of the polymeric material
A polymeric material was prepared in accordance with the present invention wherein the solid phase was composed of 99 parts by weight of 240 mesh size polyethyl methacrylate and 1 part by weight of benzoyl peroxide. The liquid portion of the composition was prepared by mixing 97.5 parts by weight of tetrahydrofurfuryl methacrylate and 2.5 parts by weight of N,N-dimethyl-p-toluidine.
The solid and liquid phases were then blended (in the ratio 1.0 g powder to 0.624 g liquid) at 200C to form, after about 5 mins, a dough-like composition which, after a further 10 mins, had hardened to a solid resin.
b. The procedure of Example 1 a was repeated except that the ratio of solid to liquid that was blended was 1.2 g to 0.624 g.
c. The procedure of Example 1 a was repeated except that the ratio of solid to liquid that was blended was 1.5 g to 0.624 g.
Example 2
Polymerisation shrinkage
The linear polymerisation shrinkage of the polymeric material produced in Example 1 b and of two known materials was measured on the apparatus illustrated in Figure 1. Referring to Figure 1, the polymerisation shrinkage apparatus consists of glass tube 1 standing on a glass slab 2.
A dial gauge 3 has a numbered face 4 and a freely movable indicating arm 5 that projects into the body of the glass tube 1 in parallel relation with the side walls 6 of the tube 1.
In use freshly mixed polymeric material 7 is introduced into the glass tube 1 and a plug 8 of the same material in a hardened state is placed on top of the freshly mixed polymer 7. The bottom of the indicating arm 5 is then put in contact with the plug 8 and as the freshly mixed material 7 hardens it also shrinks and thereby moves the plug 8 and the arm 5 further into the tube 1. The amount of linear shrinkage is indicated on the dial's numbered face 4.
The linear shrinkage of one of the polymeric materials of the present invention and two known acrylate polymers is illustrated in Figure 2.
The constituents of the three compositions are listed below.
Polyethyl methacrylate/tetrahydrofurfuryl methacrylate (PEM/THM)
Polyethylmethacrylate 1.888 g
Benzoyl peroxide 0.012 9 Tetrahydrofurfuryl methacrylate 0.608 g
N,N-Dimethyl-p-toluidine 0.016g Polymethyl methacrylate/methyl methacrylate (PMM/MM)
Polymethyl methacrylate 1.188 9 Benzoyl peroxide 0.012 9 Methyl methacrylate 0.608 g
N,N-Dimethyl-p-toluidine 0.0169 Polymethyl methacrylate/n-Butyl methacrylate (PEM/BM)
Polymethyl methacrylate 1.1889 Benzoyi peroxide 0.012 g n-Butyl methacrylate 0.608 g N,N-Dimethyl-p-toluidine 0.0169 Example 3
Viscoelastic properties
The viscoelastic properties of the polymeric materials prepared by the methods of Examples 1 a, 1b and lcwere measured by the torsional pendulum procedure described in M. Braden et al, JDent Res, 1968, 47, 519. The variation of shear modulus (real and imaginary, G, and G2 respectively) and mechanical loss tangent (tan 8) against temperature were plotted graphically to determine the
Transition Temperature (Tg) of each polymeric material.
It was found that Tg increased with increasing Tetrahydrofurfuryl methacrylate content and that the viscoelastic properties were temperature dependent in the range 20-370C.
Example 4
Mechanical properties
Rectangular strips of polyethyl methacrylate/tetrahydrofurfuryl methacrylate polymeric material (6x0.5x0.15 cm) were prepared according to the process of Example 1 b. One end of each strip was clamped and, at the other end, the deflection (y) was measured with a travelling microscope for a series of added loads (W). Youngs Modulus (E) was calculated from the slope of the linear y-W relationship using the standard cantiliver beam formula:
313gW
y
Ebd3 where l=the distance from the beam support to the point at which the load was applied, b=specimen width, d=specimen depth, g=acceleration due to gravity.
By this method the Young's Modulus of the polymeric material was found to be 1.0 GN/m2.
Example 5
Water absorption and solubility
Specimens of the polymeric material having the polymer/monomer ratio of Example 1 b were prepared in the form of a flat sheet. Each specimen was immersed in water at 37"C and weighed at suitable intervals until the absorption process was complete. The samples were then transferred to an air oven set at 370C and weighing was continued during desorption until equilibrium was again established.
Classical diffusion theory shows that for the early stages of water uptake, the ratio Mt/Moo, ie the ratio of uptake at time t to the uptake at equilibrium, is given by, Mt/Moo=2(Dt/l2). The thickness of the specimen is 21, and D is the diffusion coefficient. Mt/Moo plotted against tzF is linear.
Similar conditions apply to desorption, except that Mt will refer to water loss.
The slope of the linear region that is obtained when Mt/Moo is plotted against t+ allow D(sorption) and D(desorption) to be calculated from the above equations. The diffusion coefficients
Equilibrium uptake 2.2%
Diffusion coefficient (sorption) 3.4-4x 10-8 cm2 sec-'
(desorption) 9.5-10.3 x 1 o-8 cm2 sec-'
Example 6
Polymerisation exotherm
A sample of polyethyl methacrylate/tetrahydrofurfuryl methacrylate polymeric material was mixed according to one of the processes of Example 1 a, 1 b or 1 c and put into a cylindrical cavity (1 cm diamx 1.1 cm high) drilled in a polytetrafluoroethylene block. A copper/constantan thermocouple was then inserted centrally in the material.The thermocouple was connected to a potentiometric recorder (Smiths Servoscribe Record) so that the exotherm was plotted as a function of time.
The maximum change in temperature of the same (AT) and the time taken to reach the maximum temperature (tmax) are given for various powder/monomer ratios in Table 1.
Table 1 Powder/Monomer Ratio A T( 0C) trnax(m!ns) 1.09/0.624 g 24.9-31.8 7.9-10.2 1 .2g/0.624 g 24.0--29.2 6.5- 8.6 1 .5g/0.624 g 15.0-27.8 7.7- 9.75
The range of results quoted arise from variable room temperatures.
Example 7
Preparation of a dental crown
A wax mould for a dental crown was prepared in conventional manner by the following procedure:- a. formation of a model in stone:
b. wax-up of the desired form;
c. investment of model and waxed-up form; and
d. removal of wax form followed by cleaning.
The solid and liquid phases of Example 1 b were then blended at 200C to form a dough-like composition which was placed in the wax-mould and then allowed to polymerise. Finally, the moulded article was removed from the mould and ground and/or polished to produce the finished dental crown.
Example 8
Preparation of a dental bridge or denture
An impression of the indicated area was taken using a conventional impression material, such as sodium alginate. Liquid plaster of paris was then poured into the aforementioned impression and allowed to set. Upon the model so obtained a wax model of the appliance was formed. The colour, shape and correct bite of the teeth was then ascertained in conventional manner and the chosen teeth
were set up on the wax denture, which was then invested in plaster. After the wax had been removed by boiiing the teeth were reset in their original positions.
The solid and liquid phases of Example 1 b were then blended at 200C to form a dough-like composition, which was packed into the plaster denture in place of the wax, and then allowed to polymerise. Finally the cured article was removed from the plaster mould and ground and/or polished to produce the finished dental bridge or denture.
Example 9
Preparation of a dental filling
Cavities in teeth were prepared, in conventional manner, for receiving fillings. The solid and liquid phases of Example 1 b were then blended at 200C to form a dough-like composition. This composition was then placed in the prepared cavities and allowed to harden. Finally, the filling was ground and/or polished into the required form.
Example 10
Preparation of an ear mould for a hearing aid
A conventional impression material, such as silicone rubber, was inserted into the ear canal either by means of a syringe or by hand pressing. This process was continued until the canal, concha and helix were filled with impression material. After the impression material had hardened slightly it was removed from the ear and then invested in plaster.
The solid and liquid phases of Example 1 b were then blended at 200C to form a dough-like composition, which, after the impression material was removed, was packed into the plaster mould.
After the resin had hardened, the article was removed from the mould and ground and/or polished into the required form.
Example 11
Preparation of a contact lens
A specimen of the polymeric material having the polymer/monomer ratio of Example 1 b were prepared in the form of a rod with a 1 3 mm diameter. A blank was then turned from the rod and mounted with wax on a button which was, in turn, mounted in a lathe collet.
After the blank has been given a preiiminary skin to remove the bulk of the unwanted material from its inside surface, it was mounted on a precision lathe set up for cutting a concave surface with a single-point diamond tool. The internal and external surfaces of the contact lens are then cut to provide the curve required for corneal contact Finally, the concave and convex surfaces of the lens are polished on a polishing machine using a suitable polishing compound.
Example 12
Preparation of an artificial eye
A conventional impression material, such as silicone rubber, was inserted into the eye socket by hand pressing. After the impression material had hardened slightly it was removed from the socket and then invested in plaster. From this plaster model a wax pattern was produced. This pattern was invested in plaster in the shallow half of a dental crown flask, the plaster was trimmed and smoothed and then separating medium was applied. The counterpart was cast by vibrating plaster into both halves of the flask, The flask was then closed and the plaster allowed to set. After the plaster had set the flask was reopened and the pattern was removed. The plaster was then coated with a solution of an alginate.
The solid and liquid phases of Example 1 b were then blended at 200C to form a dough-like composition, which, after further blending with the desired colouring substance (to produce the correct scleral colour), was packed into the flask. After the polymeric material had been cured, the flask was cooled and opened, and the acrylic sclera was removed.
The sclera was then drilled, filed and ground to produce a recess for the iris disc. After the iris disc had been cemented in the recess, the acrylic sclera was, if appropriate, further treated to match the patient's requirements. This further treatment may include the attachment of embroidery silk (to represent veins) to the sclera.
Finally the sclera was replaced in the dental crown flask, and dough-like material (prepared by the method of Example 1 b) was gently pressed over its (the sclera's) surface to completely encapsulate it.
The eye was again cured, and after cooling, removed from the flask. The back of the eye was polished with dental cones and cup brushes, whilst the front was abraded with cotton mops using lustre block as the polishing agent. The final polish was obtained with chamois leather mops.
Claims (33)
1. A process for the preparation of a polymeric material suitable for biomedical use and having a linear curing shrinkage of 1% or less comprises mixing a liquid component which contains, as its sole polymerisable constituent, one or more monomeric esters of general formula I
wherein R is a hydrogen atom or a methyl radical and n is 1, 2, 3 or 4, with a solid component which comprises one or more polymers selected from the group consisting of an acrylate polymer, a methacrylate polymer and a copolymer of these polymers, and initiating the polymerisation of the one or more monomeric esters in the liquid component.
2. A process according to claim 1 wherein the liquid component contains, as its sole polymerisable constituent, tetrahydrofu rfu ryl methacrylate.
3. A process according to either claim 1 or claim 2 wherein the solid component comprises one or more polymers selected from the group consisting of polymethyl methacrylate, polyethyl methacrylate, polypropyl methacrylate, polybutyl methacrylate or copolymers of two or more of these polymers.
4. A process according to claim 3 wherein the solid component comprises polyethyl methacrylate or a copolymer of polyethyl methacrylate with one of polymethyl methacrylate, polypropyl methacrylate or polybutyl methacrylate.
5. A process according to any one of claims 1 to 4 wherein the solid component further comprises up to 10% (by wt) of an inorganic filler.
6. A process according to any one of claims 1 to 5 wherein the polymerisation of the one or more monomeric esters in the liquid component is initiated by a free radical catalyst.
7. A process according to claim 6 wherein the free radical catalyst is benzoyl peroxide.
8. A process according to either claim 6 or claim 7 wherein the free radical catalyst is present in the solid component.
9. A process according to any one of claims 6 to 8 wherein the free radical catalyst is activated by a chemical activator.
10. A process according to claim 9 wherein the chemical activator is selected from the group consisting of N,N-dialkyl-p-toluidines, N,N-dialkyl anilines and N-p-tolyldialkanolamines.
11. A process according to claim 10 wherein the chemical activator is selected from the group consisting of N,N-dimethyl-p-toluidine, N,N-diethyl-p-toluidine, N,N-dimethylaniline and N-p-toluene diethanolamine.
12. A process according to any one of claims 9 to 11 wherein the chemical activator is present in the liquid component.
1 3. A process according to any preceding claim wherein the ratio of polymer in the solid component to monomeric ester in the liquid component is between 3 to 1 and 1.5 to 1 by weight.
14. A process for the preparation of a polymeric material according to claim 1 substantially as hereinbefore described with particular reference to the Figures and the Examples.
1 5. A polymeric material suitable for biomedical use and having a linear curing shrinkage of 1% or less whenever prepared by a process according to any one of claims 1 to 1 4.
1 6. A polymeric material according to claim 1 5 in the form of a biomedical appliance.
1 7. A polymeric material according to claim 1 6 in the form of a hearing aid.
1 8. A polymeric material according to claim 1 6 in the form of a tooth filling.
1 9. A polymeric material according to claim 16 in the form of a dental bridge or crown.
20. A polymeric material according to claim 1 6 in the form of dentures, an artifical eye, a contact lens or a bone cement.
21. A kit for use in the preparation of a polymeric material by a process according to claim 1 comprising a liquid component which contains, as its sole polymerisable constituent, one or more monomeric esters of general formula I
wherein R is a hydrogen atom or a methyl radical and n is 1, 2, 3 or 4, and a solid component which comprises one or more polymers selected from the group consisting of an acrylate polymer, a methacrylate polymer and a copolymer of these polymers.
22. A kit according to claim 21 wherein the liquid component contains, as its sole polymerisable constituent, tetrahydrofurfuryl methacrylate.
23. A kit according to either claim 21 or claim 22 wherein the solid component comprises one or more polymers selected from the group consisting of polymethyl methacrylate, polyethyl methacrylate, polypropyl methacrylate, polybutyl methacrylate or copolymers of two or more of these polymers.
24. A kit according to claim 23 wherein the solid component comprises polyethyl methacrylate or a copolymer of polyethyl methacrylate with one of polymethyl methacrylate, polypropyl methacrylate or polybutyl methacrylate.
25. A kit according to any one of claims 21 to 24 wherein the solid component further comprises up to 10% (by wt.) of an inorganic filler.
26. A kit according to any one of claims 21 to 25 further comprising a polymerisation initiator which is a free radical catalyst.
27. A kit according to claim 26 wherein the free radical catalyst is benzoyl peroxide.
28. A kit according to either claim 26 or claim 27 wherein the free radical catalyst is present in the solid component.
29. A kit according to any one of claims 26 to 28 further comprising a chemical activator of the free radical catalyst.
30. A kit according to claim 29 wherein the chemical activator is selected from the group consisting of N,N-dialkyl-p-toluidines, N,N-dialkyl anilines and N-p-tolyldialkanolamines.
31. A kit according to claim 30 wherein the chemical activator is selected from the group consisting of N,N-dimethyl-p-toluidine, N,N-diethyl-p-toluidine, N,N-dimethylaniline and N-p-toluene diethanolamine.
32. A process according to any one of claims 29 to 31 wherein the chemical activator is present in the liquid component.
33. A kit for use in the preparation of a polymeric material by a process according to claim 1 substantially as hereinbefore described.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB08228973A GB2107341B (en) | 1981-10-12 | 1982-10-11 | Low shrinkage polymer/monomer mixtures for biomedical use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8130758 | 1981-10-12 | ||
GB08228973A GB2107341B (en) | 1981-10-12 | 1982-10-11 | Low shrinkage polymer/monomer mixtures for biomedical use |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2107341A true GB2107341A (en) | 1983-04-27 |
GB2107341B GB2107341B (en) | 1985-10-23 |
Family
ID=26280946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08228973A Expired GB2107341B (en) | 1981-10-12 | 1982-10-11 | Low shrinkage polymer/monomer mixtures for biomedical use |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2107341B (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0129725A2 (en) * | 1983-05-26 | 1985-01-02 | Union Carbide Corporation | Improved low shrinking curable poly(acrylate) molding compositions |
GB2261672A (en) * | 1991-11-18 | 1993-05-26 | Michael Braden | The use of biomaterials for tissue repair |
EP0709387A1 (en) * | 1994-10-26 | 1996-05-01 | Ivoclar Ag | Bicycloaliphatic 2-methylene-1,3-dioxepanes |
WO1998030192A1 (en) * | 1997-01-13 | 1998-07-16 | Davis Schottlander & Davis Limited | Improvements in or relating to polymerisable cement compositions |
CN113491790A (en) * | 2021-07-19 | 2021-10-12 | 中国科学技术大学 | Antibacterial bone cement and preparation method and application thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9501183D0 (en) * | 1995-01-19 | 1995-03-08 | Eastman Dental Inst | Flouride releasing biomaterials |
-
1982
- 1982-10-11 GB GB08228973A patent/GB2107341B/en not_active Expired
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0129725A2 (en) * | 1983-05-26 | 1985-01-02 | Union Carbide Corporation | Improved low shrinking curable poly(acrylate) molding compositions |
EP0129725A3 (en) * | 1983-05-26 | 1986-04-23 | Union Carbide Corporation | Improved low shrinking curable poly(acrylate) molding compositions |
GB2261672A (en) * | 1991-11-18 | 1993-05-26 | Michael Braden | The use of biomaterials for tissue repair |
EP0709387A1 (en) * | 1994-10-26 | 1996-05-01 | Ivoclar Ag | Bicycloaliphatic 2-methylene-1,3-dioxepanes |
US5703249A (en) * | 1994-10-26 | 1997-12-30 | Ivoclar Ag | Bicycloaliphatic 2-methylene-1,3-dioxepanes |
WO1998030192A1 (en) * | 1997-01-13 | 1998-07-16 | Davis Schottlander & Davis Limited | Improvements in or relating to polymerisable cement compositions |
US6313192B1 (en) | 1997-01-13 | 2001-11-06 | Davis Schottlander And Davis Limited | Polymerizable cement compositions |
CN113491790A (en) * | 2021-07-19 | 2021-10-12 | 中国科学技术大学 | Antibacterial bone cement and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
GB2107341B (en) | 1985-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4536158A (en) | Oral prosthesis and method for producing same | |
US4547327A (en) | Method for producing a porous prosthesis | |
US2234993A (en) | Process of manufacturing articles of thermoplastic synthetic resins | |
AU2015215533B2 (en) | Material for denture base, denture base, method of manufacturing the denture base, plate denture, and method of manufacturing the plate denture | |
WO1991012776A1 (en) | Preloaded thermoplastic dental impression tray | |
CA2034165A1 (en) | Blended polycaprolactone thermoplastic molding composition | |
US4457713A (en) | Denture forming method | |
BG97926A (en) | Biocompatible polymer material capable of casting | |
AU561971B2 (en) | Oral prosthesis and method for producing same | |
GB2107341A (en) | Low shrinkage polymer/monomer mixtures for biomedical use | |
EP0088845A2 (en) | Low shrinkage polymers and process for their preparation | |
JPS5949251B2 (en) | molding composition | |
WO2010087954A2 (en) | Hybrid polymer network compositions for use in dental applications | |
JPH05241499A (en) | Tooth model | |
Mohamed | Evaluation of bond strength between nanohybrid composite teeth and two different denture base materials (comparison study) | |
JP3922746B2 (en) | Molding agent and molding method | |
Gettleman et al. | Porous, heat cured poly (methyl methacrylate) for dental implants | |
KR100485664B1 (en) | Light Artificial Eye Having A Stereo, Transparent Iris and A Process for Producing the Same | |
KR100485657B1 (en) | Light Artificial Eye and A Process For Producing the Same | |
Roberts | Flexible casts used in making indirect interim restorations | |
Goutam et al. | DENTAL POLYMERS AND DENTURE BASE RESINS | |
RU2171104C1 (en) | Method for producing acryl base of microwave polymerization | |
Humoudi | Dimensional stability of acrylic denture base material after poly vinyl pyrrolidone addition | |
JP2002119523A (en) | Soft lining material for dental plate and method of liming dental plate using this lining material | |
Braden | Polymers and Polymer Science in Dentistry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20011011 |